医学全在线
医学全在线首页-开云app安装不了怎么办 -药师-护士-卫生资格-高级职称-考试题库-网校-考研-图谱-下载-招聘  
分类
国家级省级浙江省各省杂志
科技核心北大核心CSCDCSCD扩展
工具
期刊知识写作指导 论文投稿推荐期刊
期刊验证论文检测 录用通知往期目录
SCI
SCI指导影响因子
期刊点评基金动态
其它
经济教育计算机
建筑体育农业
北京|天津|河北|山西|湖北|江苏|安徽|山东|上海|浙江|江西|福建|湖南|宁夏|内蒙古|河南
四川|重庆|贵州|云南|辽宁|吉林|广东|广西|海南|陕西|甘肃|新疆|青海|卫生部直属|黑龙江|兵团
您现在的位置: 医学全在线 > 医学论文 > 论文投稿 > 正文:医学论文范文:复灌时参附注射液处理可减轻大鼠心肌缺血/再灌注损伤
    

医学论文范文:复灌时参附注射液处理可减轻大鼠心肌缺血/再灌注损伤

来源:本站原创 更新:2013-9-24 论文投稿平台

医学论文范文:复灌时参附注射液处理可减轻大鼠心肌缺血/再灌注损伤

【摘要】 目的 观察复灌时参附注射液处理对大鼠心肌缺血/再灌注损伤的影响。方法 利用大鼠Langendorff离体心脏灌流模型,制备心肌缺血再灌注损伤模型,在心脏缺血后再灌注同时给予参附注射液,观察大鼠心脏左室舒张末压(LVEDP)、左室发展压(LVDP)、左室内压最大变化速率(±dp/dtmax)和心率(HR),以及心肌组织中的ATP含量、丙二醛(MDA)含量、超氧化物歧化酶(SOD)活性、冠脉流出液中肌酸激酶(CK)含量的变化。实验分为4组:正常对照组、单纯缺血/再灌注组、参附注射液30 ml/L组和60 ml/L组。结果 缺血/再灌注组大鼠心肌ATP含量和SOD活性明显降低,MDA和CK含量明显升高。与缺血/再灌注组比较,参附注射液60 ml/L组心肌MDA值减少,SOD值升高,ATP含量增加,冠脉流出液CK含量减少;血流动力学指标明显改善。结论 复灌时参附注射液处理可提高心肌组织ATP含量和SOD活性,减少MDA生成,减少CK含量,保护缺血/再灌注后的大鼠心脏。

【关键词】 参附注射液;心肌;缺血再灌注

Simultaneous Shenfu injection treatment during reperfusion mitigates ischemia/reperfusion myocardium injury in isolated rat hearts

XU Pengcheng, FENG Haorong, DAI Tijun

1. Jiangsu Provincial Key Laboratory of Anesthesiology, Xuzhou, Jiangsu 221002, China; 2. Department of Anesthesiology, 98th Hospital of PLA, Huzhou, Zhejiang 313000;3. Department of Anesthetic Pharmacology, Xuzhou Medical College, Xuzhou, Jiangsu 221004医学 全在.线提供www.lindalemus.com

Abstract: Objective To investigate the effect of simultaneous treatment with Shenfu injection (SF) during reperfusion on myocardial ischemia/reperfusion injury in rats. Methods The myocardial ischemia/reperfusion model was prepared based on the Langendorff model for the perfusion of isolated rat heart. Following ischemia, reperfusion was allowed with SF injection administered simultaneously. The hemodynamic variables, such as left ventricular end-diastolic pressure (LVEDP), left ventricular developed pressure (LVDP), rate of left ventricular pressure development/relaxation (±dp/dtmax) and heart rate (HR), and the content of adenosine triphosphate (ATP), malendialdehyde (MDA), superoxide dismutase (SOD) in myocardial tissue and the activities of creatine kinase (CK) in coronary effluent fluid were observed. The isolated perfused rat hearts were separated into control, ischemia/reperfusion, SF 30 ml/L and SF 60 ml/L groups. Results In the ischemia/reperfusion group, the content of ATP and activity of SOD significantly decreased; the activities of MDA and CK significantly increased. SF 60 ml/L attenuated the decrease of SOD and the increase of MDA and CK compared with the ischemia/reperfusion group. SF 60 ml/L significantly improved the recovery of the hemodynamic variables and myocardial ATP concentrations following ischemia and reperfusion. Conclusion Simultaneous SF treatment during reperfusion could provide the cardiac protection effect against the ischemia/reperfusion injury by increasing the content of ATP and activity of SOD and decreasing the activity of MDA and CK in myocardial.

Key words: Shenfu injection; myocardium; ischemia/reperfusion

参附注射液是一种中药针剂,由红参和黑附片提取物组成, 主要有效成分为人参皂苷和乌头碱,目前临床已广泛用来治疗心绞痛心肌梗死心力衰竭等疾患,也被用于体外循环心脏瓣膜置换术[1-3]。近年来,实验已证实在缺血前应用参附注射液对缺血/ 再灌注损伤心肌有保护作用[4-5]。但复灌时应用参附注射液对心肌缺血/再灌注损伤的作用如何尚不十分清楚,本实验采用Langendorff 大鼠离体心脏灌流模型, 观察复灌后应用参附注射液对离体大鼠心脏缺血/再灌注后血流动力学以及组织中的高能磷酸化合物ATP含量的影响,为临床治疗用药提供实验基础。


[1] [2] [3] [4] 下一页

...
关于我们 - 联系我们 -版权申明 -诚聘英才 - 网站地图 - 网络课程 - 帮助
医学全在线 版权所有© CopyRight 2006-2046,
浙ICP备12017320号
百度大联盟认证绿色会员实名网站 360认证可信网站 中网验证
Baidu
map